Printer Friendly
The Free Library
6,672,335 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Woodside Biomedical's ReliefBand Selected as a Finalist in UCSD Connect's New Product Competition.


Business Editors and Health/Medical Writers

CARLSBAD, Calif.--(BW HealthWire)--Nov. 1, 2000

Woodside Biomedical, Inc.'s ReliefBand(R) device was selected as one of three finalists in the University of California, San Diego UCSD is consistently ranked among the top ten public universities for undergraduate education in the United States by U.S. News & World Report.[3] It is a Public Ivy. [1] For graduate studies, most of UCSD's Ph.D.  (UCSD UCSD University of California, San Diego (La Jolla, California)
UCSD User Centered System Design
UCSD Urbana-Champaign Sanitary District (Illinois)
UCSD Ultra Cool Sexy Dudes
) CONNECT's Most Innovative New Products awards in the life science category, announced Greg Gruzdowich, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of the Carlsbad, Calif.-based medical device manufacturer. The award honors San Diego-based medical device, instrumentation and health care products that substantially advance medical technology.

The ReliefBand, a drug-free, non-invasive device for the relief of nausea and vomiting Nausea and Vomiting Definition

Nausea is the sensation of being about to vomit. Vomiting, or emesis, is the expelling of undigested food through the mouth.
, is available over-the-counter for motion sickness, including airsickness airsickness: see motion sickness. , carsickness carsickness /car·sick·ness/ (kahr´sik-nes) motion sickness due to automobile or other vehicular travel.

car·sick·ness
n.
A form of motion sickness caused by travel in a motor vehicle.
 and seasickness seasickness: see motion sickness. . The device is also available by prescription to treat nausea and vomiting due to morning sickness and chemotherapy, as well as for post-operative nausea.

"Given the stiff competition in one of the hottest biotechnology communities in the country, we are thrilled that the ReliefBand was selected as a finalist in the life science category of the UCSD CONNECT competition," stated Gruzdowich.

Twenty San Diego medical companies and health organizations applied to UCSD CONNECT for consideration in the life sciences category. Founded in 1988, past winners in the life science category include Biosite Diagnostics, Inc. and Idec Pharmaceuticals, Inc. The 2000 Most Innovative New Products awards are sponsored by Gray Cary-Technology's Legal Edge, CB Richard Ellis CB Richard Ellis Group, Inc. NYSE: CBG is a multinational real estate corporation currently based in Los Angeles, California, U.S.A.. On December 20, 2006, the corporation, also known as CBRE, completed acquisition of Trammell Crow Co. in a transaction valued at $2. , Inc., INFLOW, Inc., KPBS, Marsh, PricewaterhouseCoopers LLP LLP - Lower Layer Protocol , Silicon Valley Bank, San Diego Union-Tribune, and Alitum.

About the ReliefBand

The ReliefBand device uses gentle electrical signals to stimulate nerves in the wrist. This wrist stimulation, according to the theory of action proposed by some researchers, causes natural nerve impulses to travel up the arm into the spinal cord and brain. It is believed that these natural nerve impulses interfere with the nausea messages going to the stomach. The ReliefBand is easy-to-use, is not a drug and -- because it is drug-free -- doesn't cause drug-drug interactions or drowsiness. The device's effects last as long as it is worn.

About Woodside Biomedical

Woodside Biomedical, Inc., based in Carlsbad, is on the forefront of developing technology-based drug-free, non-invasive medical devices that provide a therapeutic effect. Woodside is a privately-owned, venture-financed company. To date, the company has raised approximately $32 million from top-tier investors such as Patricof & Co. Ventures, Inc., Mayfield Fund, Menlo Ventures, Sequel Venture Partners, and Enterprise Partners. Additional information about the company and the ReliefBand device can be obtained from Woodside's web site at www.reliefband.com.

Except for the historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties, including, but not limited to, risks and uncertainties associated with market acceptance of the ReliefBand device, whether the company will be successful in raising additional funds, the risk that sales of the ReliefBand device will not increase to target levels, and the effectiveness and marketability of medical products, as well as other risks.

ReliefBand device is a registered trademark of Woodside Biomedical, Inc.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 1, 2000
Words:481
Previous Article:Quickturn Selected by Sigma Designs for Emulation of Next-Generation Chips and Boards.
Next Article:Trust Arabia Joins Entrust.Net Inc. Global Affiliate Program: Trust Arabia to Provide e-Business Security Solutions for Internet/Mobile Internet...
Topics:



Related Articles
ReliefBand Receives Insurance Reimbursement Code From Health Care Financing Administration.
Woodside Biomedical's ReliefBand Contributes to Improved Post-Operative Recovery, Study Shows.
IRWINDALE: WALKER, WOODSIDE ARE A GOOD MIX.(Sports)
WALKER TO HAVE TWICE THE FUN WOODSIDE ONE OF TEAM'S TWO DRIVERS.(News)
REGALS HOPING FOR A POSTSEASON BREAKTHROUGH.(NEWS)
WOODSIDE STILL ON TRACK; EX-SAUGUS SPEEDWAY STAR RACES TODAY AT CALIFORNIA SPEEDWAY.(NEWS)
San Diego Raises Profile in California Life Sciences Group; Gen-Probe, ResMed, CancerVax and UCSD Join Board of California Healthcare Institute.
Neoprobe Announces Lymphoseek Clinical Results.
Neoprobe Expands Lymphoseek Field of Use; Option Agreement Extends to Optical and Ultrasound Applications.
Neoprobe's Lymphoseek Issued European Patent; Neoprobe Licensed Product Patent Covers Major European Markets.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles